810222C

C6-NBD Glucosyl Ceramide

Avanti Research^™ - A Croda Brand 810222C

• 別名: N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-glucosyl-β1-1′-sphingosine
• 実験式（ヒル表記法）: C₃₆H₅₉N₅O₁₁
• CAS番号: 94885-03-7
• 分子量: 737.88
• UNSPSCコード: 12352211
• NACRES: NA.25

特性

• アッセイ: >99% (TLC)
• 形状: liquid
• 包装: pkg of 1 × 1 mL (810222C-250ug); pkg of 1 × 1 mg (81022C-1MG)
• メーカー／製品名: Avanti Research^™ - A Croda Brand 810222C
• 濃度: 0.25 mg/mL (810222C-250ug)
• 輸送温度: dry ice
• 保管温度: −20°C

詳細

詳細

C6-NBD Glucosyl Ceramide is a fluorescent derivative of biologically active compound, glucosyl ceramide. Glucosyl ceramide belongs to the class of sphingolipids that are synthesized in the cis/medial-Golgi apparatus by the glycosylation of ceramide.

アプリケーション

C6-NBD Glucosyl Ceramide may be used as a substrate for glucocerebrosidase (GCase) activity assay in Drosophila melanogaster and mice.

生物化学的／生理学的作用

Glucosylceramide is the precursor of different glycosphingolipids including gangliosides and sulfatides. Glucosyl ceramide is also known to be responsible for axon growth of neural cells. The accumulation of glucosyl ceramide is associated with an inherited lysosomal storage disorder, Gaucher′s disease.

包装

5 mL Amber Glass Screw Cap Vial (81022C-1MG)

5 mL Clear Glass Sealed Ampule (810222C-250ug)

法的情報

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全性情報

• ピクトグラム: GHS06,GHS08
• シグナルワード: Danger
• 危険有害性情報: H302,H315,H319,H331,H336,H351,H361d,H372
• 注意書き: P201 - P260 - P264 - P280 - P304 + P340 + P311 - P403 + P233
• 危険有害性の分類: Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 - STOT SE 3
• ターゲットの組織: Central nervous system
• WGK: WGK 3